相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuroprotective effect of matrine on MPTP-induced Parkinson's disease and on Nrf2 expression
Fanhua Meng et al.
ONCOLOGY LETTERS (2017)
NEWBORN DOPAMINERGIC NEURONS ARE ASSOCIATED WITH THE MIGRATION AND DIFFERENTIATION OF SVZ-DERIVED NEURAL PROGENITORS IN A 6-HYDROXYDOPAMIN-INJECTED MOUSE MODEL
M. Q. Xie et al.
NEUROSCIENCE (2017)
Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment
Xiaobo Wei et al.
MOLECULAR NEUROBIOLOGY (2016)
Identification of a Binding Site for Unsaturated Fatty Acids in the Orphan Nuclear Receptor Nurr1
Ian Mitchelle S. de Vera et al.
ACS CHEMICAL BIOLOGY (2016)
Nurr1-Based Therapies for Parkinson's Disease
Jie Dong et al.
CNS NEUROSCIENCE & THERAPEUTICS (2016)
Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo
Chenyang Shi et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
Sang-Min Oh et al.
EMBO MOLECULAR MEDICINE (2015)
Nuclear receptor Nurr1 agonists enhance its dual functions and improve behavioral deficits in an animal model of Parkinson's disease
Chun-Hyung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Theranostic mRNA-loaded Microbubbles in the Lymphatics of Dogs: Implications for Drug Delivery
Heleen Dewitte et al.
THERANOSTICS (2015)
COMPARATIVE STUDY OF THE NEUROTROPHIC EFFECTS ELICITED BY VEGF-B AND GDNF IN PRECLINICAL IN VIVO MODELS OF PARKINSON'S DISEASE
X. Yue et al.
NEUROSCIENCE (2014)
Functional Neuroprotection and Efficient Regulation of GDNF Using Destabilizing Domains in a Rodent Model of Parkinson's Disease
Luis Quintino et al.
MOLECULAR THERAPY (2013)
NURR1 in Parkinson disease-from pathogenesis to therapeutic potential
Mickael Decressac et al.
NATURE REVIEWS NEUROLOGY (2013)
RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells
Elaine L. Pranski et al.
NEUROBIOLOGY OF DISEASE (2013)
Regulated Expression of Lentivirus-Mediated GDNF in Human Bone Marrow-Derived Mesenchymal Stem Cells and Its Neuroprotection on Dopaminergic Cells In Vitro
Wei-Hua Yang et al.
PLOS ONE (2013)
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
Shelley J. Allen et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF
Ofelia M. Littrell et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Lung Surfactant Microbubbles Increase Lipophilic Drug Payload for Ultrasound-Targeted Delivery
Shashank R. Sirsi et al.
THERANOSTICS (2013)
Efficient Catalytic Reduction of Hexavalent Chromium Using Palladium Nanoparticle-Immobilized Electrospun Polymer Nanofibers
Yunpeng Huang et al.
ACS APPLIED MATERIALS & INTERFACES (2012)
Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation
Marica Carbone et al.
BMC NEUROSCIENCE (2012)
Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone
Heinz Reichmann et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
Targeted Delivery of GDNF through the Blood-Brain Barrier by MRI-Guided Focused Ultrasound
Feng Wang et al.
PLOS ONE (2012)
α-Synuclein-Induced Down-Regulation of Nurr1 Disrupts GDNF Signaling in Nigral Dopamine Neurons
Mickael Decressac et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Signaling of Glial Cell Line-Derived Neurotrophic Factor and Its Receptor GFRα1 Induce Nurr1 and Pitx3 to Promote Survival of Grafted Midbrain-Derived Neural Stem Cells in a Rat Model of Parkinson Disease
Zhinian Lei et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Identification of Bilateral Changes in TID1 Expression in the 6-OHDA Rat Model of Parkinson's Disease
Juliane Proft et al.
PLOS ONE (2011)
Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: Comparison with SonoVue
Ping Liu et al.
ULTRASONICS (2011)
Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier
Ailing Fu et al.
BRAIN RESEARCH (2010)
Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: A tool for targeted drug delivery
Alexander L. Klibanov et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Design and Evaluation of Doxorubicin-containing Microbubbles for Ultrasound-triggered Doxorubicin Delivery: Cytotoxicity and Mechanisms Involved
Ine Lentacker et al.
MOLECULAR THERAPY (2010)
The dopamine transporter is differentially regulated after dopaminergic lesion
Domingo Afonso-Oramas et al.
NEUROBIOLOGY OF DISEASE (2010)
Targeted drug delivery across the blood-brain barrier using ultrasound technique
Cheri X. Deng
THERAPEUTIC DELIVERY (2010)
Bilateral high frequency stimulation of the subthalamic nucleus normalizes COX activity in the substantia nigra of Parkinsonian rats
Rinske Vlamings et al.
BRAIN RESEARCH (2009)
Comparison of Blood-Brain Barrier Transport of Glial-Derived Neurotrophic Factor (GDNF) and an IgG-GDNF Fusion Protein in the Rhesus Monkey
Ruben J. Boado et al.
DRUG METABOLISM AND DISPOSITION (2009)
Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound
Lisa H. Treat et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model
Fabio Blandini et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles
AFH Lum et al.
JOURNAL OF CONTROLLED RELEASE (2006)
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease
J Jankovic et al.
PROGRESS IN NEUROBIOLOGY (2005)
Zeta-potential measurements as a tool to quantify the effect of charged drugs on the surface potential of egg phosphatidylcholine liposomes
C Matos et al.
LANGMUIR (2004)
Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance
GA Metz et al.
NEUROSCIENCE (2002)
Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain
NB Chauhan et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion
DM Yurek et al.
BRAIN RESEARCH (2001)
分享论文
